MétaCan
Menu
← Back to cohort
Record W7119491673 · doi:10.1002/alz70856_107210

Impact of white matter hyperintensities on disease progression in Progressive Supranuclear Palsy‐Richardson syndrome

2025· article· en· W7119491673 on OpenAlexaff
Indira García‐Cordero, Juan‐Camilo Vargas‐González, Blas Couto, Bayram Ece, Federico Rodríguez‐Porcel, Jay Iyer, Lawrence I. Golbe, Christopher D. Stephen, Alex Pantelyat, Marian L. Dale, Nikolaus McFarland, Tao Xie, Matthew Swan, Kyurim Kang, Douglas Gunzler, Anne‐Marie Wills, Adam L. Boxer, Irene Litvan, A Elang, Carmela Tartaglia

Bibliographic record

VenueAlzheimer s & Dementia · 2025
Typearticle
Languageen
FieldMedicine
TopicParkinson's Disease Mechanisms and Treatments
Canadian institutionsUniversity Health NetworkToronto Western HospitalOccupational Cancer Research CentreUniversity of Toronto
Fundersnot available
KeywordsHyperintensityNeuroimagingFramingham Risk ScoreConfidence intervalLinear regressionWhite matterFramingham Heart StudyDisease

Abstract

fetched live from OpenAlex

Abstract Background White matter hyperintensities (WMH) are recognized as neuroimaging biomarkers of cerebral small vessel disease; however, their clinical significance in Progressive Supranuclear Palsy‐Richardson syndrome (PSP‐RS) is poorly understood. Method 125 PSP‐RS patients from the Tilavonemab (ABBV‐8E12) clinical trial were assessed for disease severity using the PSP Rating Scale (PSPRS) at baseline and week 24. A PSPRS change index was calculated for week 24. WMH lesions were segmented on MRI FLAIR images using the Lesion Segmentation Tool and the total lesion volume (TLV) was calculated at baseline and week 24. The non‐laboratory Framingham Atherosclerotic Cardiovascular Disease Risk Score (FRS) was calculated in 99 patients. A linear mixed‐effect model for repeated measures was used to analyzed the TLV across the two time points. A multiple linear regression analyses was performed to analyze the association between baseline TLV, FRS, and their interaction in predicting the PSPRS change index. All analyses were adjusted for age, sex and disease duration. Result Mean age of the 125 PSP‐RS patients: 68.7 (49‐86) years, 51 females (40.8%). There was an increase of the TLV (B=0.09, 95% Confidence Intervals (CI):0.04‐0.13, p <0.001; mean±SD: 8.46±10.20 vs 9.38±10.60 ml) across time. Mean age of the 99 PSP‐RS patients with FRS: 66.8 (49‐74) years, 43 females (43.4%). Mean FRS: 20.6 ± 8.3%. A significant relationship was found between the TLV and the PSPRS change index (B=0.08, CI:0.01‐0.15, p = 0.02) and between the FRS and the PSPRS change index (B=0.11, CI:0.01‐0.21, p = 0.03). TLV*FRS shows a significant negative association with the PSPRS change index (B=‐0.01, CI:‐0.01‐ 0.00, p = 0.02). Conclusion TLV increased over time in PSP‐RS patients. For each 1 ml increase in TLV, the PSPRS change score increased by 0.11, and for each 1% increase in FRS, the PSPRS change score increased by 0.08. However, the increase must be adjusted for the combined effect, i.e., when both FRS and TLV are present, the increase is slightly smaller than the sum of their individual effects. *Based on research using data from AbbVie that has been made available through Vivli, Inc. Vivli has not contributed to or approved, and is not in any way responsible for, the contents of this publication.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.306
Teacher spread0.290 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & Dementia→Same topicParkinson's Disease Mechanisms and Treatments→French-language works237,207→